Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States of America; Division of Cardiology, Straub Medical Center, Hawaii Pacific Health, Honolulu, HI, United States of America.
Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH, United States of America.
Cardiovasc Revasc Med. 2021 Apr;25:75-85. doi: 10.1016/j.carrev.2020.10.016. Epub 2020 Oct 27.
Excimer laser coronary atherectomy (ELCA) during percutaneous coronary intervention (PCI) has been in use for more than twenty years. While early experiences were not favorable over balloon angioplasty alone, with improvement in operator technique, patient selection and technology, ELCA has established its own niche in contemporary PCI as a safe and effective atherectomy strategy. With growing experience in complex coronary interventions worldwide, ELCA has become one of the essential atherectomy tools offering unique advantages over other atherectomy devices. In the modern era, ELCA is commonly used for patients with in-stent restenosis, stent under expansion, balloon uncrossable lesions and chronic total occlusions. Technical success rates are reported to be >80% in most situations while procedural complication rates such as vessel dissection and perforation among others are reported to average 9% over the past 25 years with improvement over time. In this review, we provide a comprehensive systematic review of the ELCA system, its practical use, indications, and procedural techniques in the contemporary PCI era.
准分子激光冠状动脉斑块切除术(ELCA)在经皮冠状动脉介入治疗(PCI)中已应用超过二十年。虽然早期经验并不优于单纯球囊血管成形术,但随着手术技术、患者选择和技术的改进,ELCA 已在当代 PCI 中确立了自己的地位,成为一种安全有效的斑块切除术策略。随着全球复杂冠状动脉介入治疗经验的不断增加,ELCA 已成为一种必不可少的斑块切除术工具,与其他斑块切除术设备相比具有独特的优势。在现代,ELCA 常用于治疗支架内再狭窄、支架扩张不全、球囊不可通过病变和慢性完全闭塞病变的患者。在大多数情况下,技术成功率报告超过 80%,而过去 25 年来,血管夹层和穿孔等手术并发症的发生率报告平均为 9%,随着时间的推移有所改善。在这篇综述中,我们全面系统地回顾了 ELCA 系统,及其在当代 PCI 时代的实际应用、适应证和手术技术。